These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 365193

  • 1. [Treatment with antilymphocyte globulin (ALG) and evolution of renal transplant: observations of 42 cases].
    Civati G, Grillo C, Di Belgioioso GB, Rovati C, Surian M, Busnach G, Broggi L, Ferrari L.
    Boll Ist Sieroter Milan; 1978 May 31; 57(2):165-72. PubMed ID: 365193
    [Abstract] [Full Text] [Related]

  • 2. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants.
    Sansom JR, Barnes AD, Hall CL.
    Postgrad Med J; 1976 May 31; 52(5 Suppl):75-8. PubMed ID: 792851
    [Abstract] [Full Text] [Related]

  • 3. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
    Taylor HE, Ackman CF, Horowitz I.
    Can Med Assoc J; 1976 Dec 18; 115(12):1205-8. PubMed ID: 793705
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine.
    Halloran PF, Aprile MA, Farewell V, Ludwin D, Smith EK, Tsai SY, Bear RA, Cole EH, Fenton SS, Cattran DC.
    Transplantation; 1988 Aug 18; 46(2):223-8. PubMed ID: 3043779
    [Abstract] [Full Text] [Related]

  • 6. Antilymphocyte globulin and renal transplantation.
    Tagnon A.
    Postgrad Med J; 1976 Aug 18; 52(5 Suppl):64-6. PubMed ID: 792848
    [Abstract] [Full Text] [Related]

  • 7. The use of antilymphocyte globulin in renal allograft rejection. A controlled study.
    Birkeland SA.
    Postgrad Med J; 1976 Aug 18; 52(5 Suppl):82-8. PubMed ID: 792853
    [Abstract] [Full Text] [Related]

  • 8. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function.
    Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman R, Veith FJ.
    Transplantation; 1988 Feb 18; 45(2):406-9. PubMed ID: 3278434
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of the effectiveness of ALG in clinical kidney transplantation in alternating studies].
    Tidow G, Bunzendahl H, Wonigeit K, Pichlmayr R.
    Chir Forum Exp Klin Forsch; 1979 Feb 18; ():325-8. PubMed ID: 378593
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
    Boratyńska M, Szepietowski T, Szewczyk Z, Szydłowski Z.
    Arch Immunol Ther Exp (Warsz); 1992 Feb 18; 40(2):163-8. PubMed ID: 1299176
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M, Durrbach A, Hiesse C, Ladouceur M, Benoit G, Charpentier B.
    Transplantation; 2008 Dec 27; 86(12):1732-7. PubMed ID: 19104413
    [Abstract] [Full Text] [Related]

  • 14. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 15. [Clinical significance of immunological findings for the survival time of kidney transplants with antilymphocyte globulin therapy].
    Bullinger W, Hammer C, Land W, Welter H.
    Chir Forum Exp Klin Forsch; 1979 Jan 27; ():319-24. PubMed ID: 378592
    [Abstract] [Full Text] [Related]

  • 16. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A, Moreso FJ, Seron D, Gil-Vernet S, Cruzado JM, Castelao AM, Grinyó JM.
    Transplant Proc; 2004 Jun 27; 36(5):1305-7. PubMed ID: 15251318
    [Abstract] [Full Text] [Related]

  • 17. Experience with antilymphocyte globulin in 144 renal transplant recipients.
    Lundgren G, Collste L, Groth CG, Krzymansky M, Magnusson G, Quadracci L, Ringdén O, Svehag SE.
    Postgrad Med J; 1976 Jun 27; 52(5 Suppl):67-71. PubMed ID: 792849
    [Abstract] [Full Text] [Related]

  • 18. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
    Indudhara R, Novick AC, Hodge E, Goormastic M, Papajcik D, Mastroianni B, Cook D.
    Urology; 1996 Jun 27; 47(6):807-12. PubMed ID: 8677568
    [Abstract] [Full Text] [Related]

  • 19. Controlled trial of antilymphocyte globulin in cadaveric transplantation.
    Jakobsen J, Flatmark A, Sodal G, Thorsby E.
    Postgrad Med J; 1976 Jun 27; 52(5 Suppl):72-4. PubMed ID: 792850
    [Abstract] [Full Text] [Related]

  • 20. [Kidney retransplantation: prognostic factors in a series of 84 cases].
    Gutierrez R, Romero JA, Ricart JM, Barranco M, Oppenheimer P, Alvarez R, Talbot R, Carretero P.
    J Urol (Paris); 1992 Jun 27; 98(2):84-8. PubMed ID: 1431189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.